Table 1. Summary of clinical features.
Underlying disease | ||
UC | 58 (64%) | |
CD | 32 (36%) | |
Sex | ||
Male | 56 (62%) | |
Female | 34 (38%) | |
Age at cancer diagnosis | ||
Median (range) | 49 (27–79) | |
Age at IBD onset | ||
Median (range) | 28 (11–67) | |
Duration of IBD | ||
Median (range) | 17.8 yrs (0.2–40.5) | |
Stage | ||
0 | 4 (4%) | |
I | 13 (14%) | |
II | 36 (40%) | |
III | 26 (29%) | |
IV | 6 (7%) | |
NA | 5 (6%) |